Trials / Terminated
TerminatedNCT01874470
Renal Denervation by Allegro System in Patients With Resistant Hypertension
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Shanghai AngioCare Medical · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of ALLEGRO-HTN trial is to evaluate the safety and effectiveness of renal denervation in subjects with resistant hypertension by using Allegro renal denervation system
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | renal denervation | |
| OTHER | standard medication |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2013-06-11
- Last updated
- 2016-10-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01874470. Inclusion in this directory is not an endorsement.